CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.


In the News

October 2, 2023 | Duke School of Medicine

Using Gene Therapy to Treat Brain Disease

Doug Marchuk and Aravind Asokan have been awarded a three-year $1.9 million grant from the Department of Defense to develop less invasive treatment options for familial cerebral cavernous malformations (CCM).

boris kantor

July 20, 2023 | Cision PR Newswire

CRISPR/Gene Editing Technology Creates New Treatment Possibilities for Alzheimer's Disease

Boris Kantor and Ornit Chiba-Falek described an epigenome therapy platform based on CRISPR/dCas9-editing strategy intended to reduce APOE-e4 at the Alzheimer's Association International Conference